MFT enters data sharing collaboration with Rinicare to further develop clinical risk prediction technology
MFT has signed a collaboration and data sharing agreement with Manchester-based health technology start-up Rinicare.
Read moreResearch and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
Whole genome sequencing improves rare disease diagnosis, according to world-first study
A world-first scientific study has shown that whole genome sequencing can uncover new diagnoses for people across the broadest range of rare diseases investigated to date.
Read more
COVID-19 vaccine gave 100 per cent protection against severe/critical illness to study volunteers, research shows
Results from a COVID-19 vaccine trial – to which MFT consented the first global participant – are ‘extremely positive’.
Read more
‘Promising’ new way to predict older mums’ pregnancy risks revealed
Saint Mary's researchers have revealed new ways of calculating older mums’ personal risk of serious pregnancy problems like having stillborn, premature, or very small babies.
Read more
Manchester-led international research collaboration link genes to condition which causes hearing loss and infertility
Research led by Professor Bill Newman, Consultant at MFT, could revolutionise the diagnosis and treatment for people with Perrault syndrome.
Read more
Action needed on high mortality in children with adrenal insufficiency
Children with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.
Read more
Pioneering MFT research featured in national cancer exhibition
Pioneering care and research across Manchester University Hospitals NHS Foundation Trust (MFT) features in a new national exhibition on cancer breakthroughs.
Read more
Implantable tech could be a game-changer for heart patients
Implantable heart technology is being used in Manchester to assess when a patient is at high risk of dying, thanks to Manchester University NHS Foundation Trust-led research.
Read more
